Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Thousand Oaks, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Atara Biotherapeutics, Inc. has filed 1,129 SEC EDGAR filings since 10 Apr 2014

SEC filing history

Showing 776-800 of 1,000 matching filings.

Per page
25
Current page
32
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8K - 2017 ANNUAL MEETING RESULTS

Filing date
08 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 May 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
11 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K Q1 2017 EARNINGS RELEASE

Filing date
04 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Apr 2017
Reporting date
25 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36548

DEFA14A

Filing date
25 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36548

DEF 14A

Filing date
25 Apr 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88393

13G

Filing date
21 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
20 Apr 2017
Reporting date
20 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .